A Phase II Clinical Trial of Chiglitazar for NASH
Clinical trial NCT05193916 · COMPLETED
Trial details
- NCT number
- NCT05193916
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2024-01-02
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.